FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Clears Bodyport Cardiac Fluid Scale

[ Price : $8.95]

FDA clears a Bodyport 510(k) for its biomarker platform Bodyport Cardiac Scale that is intended to assess measures of heart functi...

CorMedix Hit With 2nd Complete Response on DefenCath

[ Price : $8.95]

FDA sends CorMedix a second complete response letter on its NDA for DefenCath (taurolidine/heparin catheter lock solution) for use...

Objectionable Conditions at Valley Biosystems

[ Price : $8.95]

FDA warns West Sacramento, CA-based Valley Biosystems about violations in its conduct of two nonclinical laboratory studies.

QS, MDR Violations at InfuTronix

[ Price : $8.95]

FDA warns Natick, MA-based Infutronix about Quality System and Medical Device Reporting violations in its production of infusion p...

EUA for Modified Administration of Monkeypox Vaccine

[ Price : $8.95]

FDA issues Bavarian Nordic an emergency use authorization for its smallpox/monkeypox vaccine Jynneos to allow healthcare providers...

Understanding Drug Risks and Benefits in Tweets

[ Price : $8.95]

CDER advertising researchers say their study of character-space-limited communications like Tweets in terms of drug benefit and ri...

Amazon Distributing Unapproved New Drugs: FDA

[ Price : $8.95]

FDA warns Amazon.com that its fulfillment service is distributing unapproved new drugs sold over-the-counter as mole and skin tag ...

FDA Extends Review of Reata Pharma NDA

[ Price : $8.95]

FDA extends by three months the review of a Reata Pharmaceuticals NDA for omaveloxolone to allow time to evaluate additional data ...

Allergenic Products Advisory Panel Renewed

[ Price : $8.95]

Federal Register notice: FDA renews its Allergenic Products Advisory Committee for an additional two years beyond the charter expi...

50 NDAs Not Withdrawn Due to Safety/Efficacy: FDA

[ Price : $8.95]

Federal Register notice: FDA determines that 50 listed drug products were not withdrawn for safety or effectiveness reasons.